Sarda Proteins Ltd (SRDAPRT) Fair Value & Analysis
Consumer Defensive · IN · Market cap ₹161M
Fair value as of: Jul 6, 2026
From 14 valuation models · updated yesterday
Share price +5.0% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹63.06 – ₹144.30 · fair‑value band ₹79.97 – ₹93.30 · the ₹93.13 price screens above the ₹87.58 fair value. As of Jul 6, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Sarda Proteins Ltd (SRDAPRT) currently trades at ₹93.13, while our model-based Fair Value estimate is ₹87.58 — implying the stock looks roughly 6.0% overvalued today. We read business quality at 61/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Over the trailing twelve months, Sarda Proteins Ltd generated revenue of ₹162M at a net margin of 4.0%. It earns a return on equity of 23.7%. Fundamentals as of Jul 6, 2026
Our scenario range runs from ₹79.97 (bear case) to ₹93.30 (bull case); at ₹93.13, the current price sits within that range. The share trades about 35% below its 52-week high and 55% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -27% fair-value upside — at -6%, SRDAPRT screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.
About the company
Sarda Proteins Ltd trades in edible oils and agri commodities in India. It is involved in trading mustard oil and mustard oil cake, as well as soya refined oil; and agricultural commodities, such as oil seeds, grains, and edible oils. The company also provides manpower services. Sarda Proteins Ltd was incorporated in 1991 and is based in Jaipur, India.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Sarda Proteins Ltd reported revenue of ₹242M in FY2025 versus ₹114M in FY2021, a compound +20.8%/yr. Reported net income was ₹51.0K in FY2025.
Is SRDAPRT fairly valued? → Check now
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 6, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé S.A NSRGF | $98.25 | $65.41 | -33% |
| Nestlé India Limited NESTLEIND | ₹1,402 | ₹362.37 | -74% |
| Grupo Bimbo, S.A. BIMBOA | 57.10 MXN | 45.03 MXN | -21% |
| Uni-President Enterprises Corp 1216 | 75.60 TWD | 55.53 TWD | -27% |
| Britannia Industries Limited BRITANNIA | ₹5,171 | ₹1,966 | -62% |
| Tata Consumer Products Limited TATACONSUM | ₹1,108 | ₹328.05 | -70% |
| ICBP ICBP | 6,250 IDR | 10,177 IDR | +63% |
| Samyang Foods Co 003230 | 1,000,000 KRW | 1,066,643 KRW | +7% |
| Patanjali Foods Limited PATANJALI | ₹420.45 | ₹294.68 | -30% |
| Vietnam Dairy Products Joint Stock Company VNM | 58,600 VND | 68,035 VND | +16% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Sarda Proteins Ltd (SRDAPRT) undervalued?
What is the fair value of SRDAPRT?
What is the quality score of SRDAPRT?
What is the revenue of Sarda Proteins Ltd (SRDAPRT)?
What is the net profit margin of SRDAPRT?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.